药品名称CAPOZIDE 25/15
申请号018709产品号001
活性成分CAPTOPRIL; HYDROCHLOROTHIAZIDE市场状态停止上市
剂型或给药途径TABLET;ORAL规格25MG;15MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
治疗等效代码参比药物
批准日期1984/10/12申请机构APOTHECON INC DIV BRISTOL MYERS SQUIBB
化学类型New combination审评分类Standard review drug
与本品相关的专利信息(来自橙皮书Orange Book)
专利号专利过期日是否化合物专利是否产品专利专利用途代码专利下载
历史专利信息
与本品相关的市场独占权保护信息
独占权代码失效日期
历史市场独占权保护信息
与药品注册相关的信息
申请号修订号审批结论公开文档类型文档创建时间获取文档
018709035APLetter2009/03/03下载
018709033APLetter2006/05/21下载
药品注册审批历史信息
申请号修订号审批结论审批日期审批内容
018709035AP2009/02/26Labeling Revision
018709033AP2006/05/16Labeling Revision
018709031AP1997/05/20Control Supplement
018709030AP1998/06/03Labeling Revision
018709029AP1996/06/26Manufacturing Change or Addition
018709028AP1996/03/04Control Supplement
018709027AP1996/07/31Labeling Revision
018709026AP1996/07/31Labeling Revision
018709025AP1995/10/06Manufacturing Change or Addition
018709024AP1993/05/12Package Change
018709023AP1992/10/15Labeling Revision
018709022AP1992/06/25Labeling Revision
018709021AP1994/07/25Labeling Revision
018709020AP1992/03/05Package Change
018709019AP1991/12/10Manufacturing Change or Addition
018709018AP1990/09/05Package Change
018709017AP1991/03/21Labeling Revision
018709016AP1990/09/27Labeling Revision
018709015AP1989/05/03Labeling Revision
018709014AP1989/10/19Labeling Revision
018709012AP1988/06/22Labeling Revision
018709011AP1987/10/06Control Supplement
018709010AP1987/01/06Package Change
018709009AP1991/10/24New or Modified Indication
018709008AP1986/01/17Labeling Revision
018709007AP1985/08/02Labeling Revision
018709006AP1985/07/15Package Change
018709005AP1986/11/10Control Supplement
018709004AP1985/07/03Package Change
018709003AP1985/08/01Package Change
018709002AP1985/02/07Package Change
018709001AP1984/11/20Control Supplement
018709000AP1984/10/12Approval